1. World Health Organization. Global tuberculosis report 2015. Available at http://www.who.int/tb/publications/global_report/en/. Accessed on January 6, 2016.
2. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa;TAS Group,2015
3. Hosseinipour M, Bisson G, Miyahara S, Sun X, Moses A, Riviere C, et al. Empiric TB therapy does not decrease early mortality compared to isoniazid preventive therapy in adults with advanced HIV initiating ART: results of ACTG A5274 (REMEMBER study). 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), Vancouver, Canada, 19–22 July 2015 (abstract MOAB0205LB).
4. Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability;S Srivastava,2011
5. Editorial commentary: pharmacokinetic variability and tuberculosis treatment outcomes, including acquired drug resistance;EF Egelund,2012